Indian startup Oxyzo, the lending arm of B2B financing startup OfBusiness, raises a $200M Series A at a $1B valuation led by Alpha Wave
Harsh Upadhyay / Entrackr :
Context & Ripple Effects
Oxyzo's $1B debut comes on the back of an extraordinary funding run by its parent: OfBusiness went from a $160M round at a $1.5B valuation in July to a Tiger Global-led $200M Series F at $3B in September, then closed a $325M Series G at roughly $5B in December. Spinning the lending arm out as its own billion-dollar company extends that momentum into a separate cap table.
First-order effects
- Alpha Wave's lead gives Oxyzo fresh balance-sheet capacity to lend against OfBusiness's B2B commerce flows, while the parent earmarks its own new capital for acquisitions and operational expansion.
- The deal makes Oxyzo a unicorn at Series A — a valuation milestone its parent needed three rounds and five months to reach in 2021.
Second-order effects
- Dedicated SMB lenders like Aye Finance now face a competitor whose underwriting data comes from an integrated B2B procurement platform rather than standalone loan applications.
- Investors choosing between India SMB-finance bets — from Zetwerk's supply-chain marketplace to Open's neobanking — must price in a rival that owns both the transaction flow and the credit book.
Third-order effects
- If the pattern holds, Indian B2B platforms will keep carving their financing operations into separately capitalized unicorns, letting each arm raise against its own risk profile while deepening the concentration of late-stage capital among a small set of cross-border funds like Alpha Wave and Tiger Global.
The trend: Indian B2B commerce startups are splitting their lending arms into independently funded unicorns, turning embedded finance into a standalone asset class for global growth investors.